Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?.

Thrombosis research

Hell L, Thaler J, Martinod K, Ay C, Posch F, Wagner DD, Pabinger I.
PMID: 27161688
Thromb Res. 2016 Apr;140:S174-5. doi: 10.1016/S0049-3848(16)30133-5. Epub 2016 Apr 08.

INTRODUCTION: Overt disseminated intravascular coagulation (DIC) is a systemic process characterized by excessive coagulation activation and fibrinolysis that may occur in cancer patients. The underlying pathomechanisms are still poorly understood. Recent experimental studies found an important role for the...

Cite
Hell L, Thaler J, Martinod K, et al. OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?. Thromb Res. 2016;140:S174-5doi: 10.1016/S0049-3848(16)30133-5.
Hell, L., Thaler, J., Martinod, K., Ay, C., Posch, F., Wagner, D. D., & Pabinger, I. (2016). OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?. Thrombosis research, 140S174-5. https://doi.org/10.1016/S0049-3848(16)30133-5
Hell, L, et al. "OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?." Thrombosis research vol. 140 (2016): S174-5. doi: https://doi.org/10.1016/S0049-3848(16)30133-5
Hell L, Thaler J, Martinod K, Ay C, Posch F, Wagner DD, Pabinger I. OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?. Thromb Res. 2016 Apr;140:S174-5. doi: 10.1016/S0049-3848(16)30133-5. Epub 2016 Apr 08. PMID: 27161688.
Copy Download .nbib Format: NLM
Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages.

BMC bioinformatics

Dander A, Baldauf M, Sperk M, Pabinger S, Hiltpolt B, Trajanoski Z.
PMID: 25230706
BMC Bioinformatics. 2014 Sep 18;15:306. doi: 10.1186/1471-2105-15-306.

BACKGROUND: Cancer immunotherapy has recently entered a remarkable renaissance phase with the approval of several agents for treatment. Cancer treatment platforms have demonstrated profound tumor regressions including complete cure in patients with metastatic cancer. Moreover, technological advances in next-generation...

Cite
Dander A, Baldauf M, Sperk M, et al. Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages. BMC Bioinformatics. 2014;15:306doi: 10.1186/1471-2105-15-306.
Dander, A., Baldauf, M., Sperk, M., Pabinger, S., Hiltpolt, B., & Trajanoski, Z. (2014). Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages. BMC bioinformatics, 15306. https://doi.org/10.1186/1471-2105-15-306
Dander, Andreas, et al. "Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages." BMC bioinformatics vol. 15 (2014): 306. doi: https://doi.org/10.1186/1471-2105-15-306
Dander A, Baldauf M, Sperk M, Pabinger S, Hiltpolt B, Trajanoski Z. Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages. BMC Bioinformatics. 2014 Sep 18;15:306. doi: 10.1186/1471-2105-15-306. PMID: 25230706; PMCID: PMC4261581.
Copy Download .nbib Format: NLM
Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding.

Wiener klinische Wochenschrift

Gremmel T, Niessner A, Domanovits H, Frossard M, Sengölge G, Steinlechner B, Sycha T, Wolzt M, Pabinger I.
PMID: 30796518
Wien Klin Wochenschr. 2019 Mar;131(5):135. doi: 10.1007/s00508-019-1467-8.

Correction to: Wien Klin Wochenschr 2018 https://doi.org/10.1007/s00508-018-1381-5 Unfortunately, the original version of this article contained two mistakes.The text passage "It should be mentioned here that in the case of apixaban, dose adjustment is not based on GFR. A lower...

Cite
Gremmel T, Niessner A, Domanovits H, et al. Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding. Wien Klin Wochenschr. 2019;131(5):135doi: 10.1007/s00508-019-1467-8.
Gremmel, T., Niessner, A., Domanovits, H., Frossard, M., Sengölge, G., Steinlechner, B., Sycha, T., Wolzt, M., & Pabinger, I. (2019). Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding. Wiener klinische Wochenschrift, 131(5), 135. https://doi.org/10.1007/s00508-019-1467-8
Gremmel, Thomas, et al. "Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding." Wiener klinische Wochenschrift vol. 131,5 (2019): 135. doi: https://doi.org/10.1007/s00508-019-1467-8
Gremmel T, Niessner A, Domanovits H, Frossard M, Sengölge G, Steinlechner B, Sycha T, Wolzt M, Pabinger I. Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding. Wien Klin Wochenschr. 2019 Mar;131(5):135. doi: 10.1007/s00508-019-1467-8. PMID: 30796518; PMCID: PMC6828200.
Copy Download .nbib Format: NLM
Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston.

Online journal of public health informatics

Reid M, Gunn J, Shah S, Donovan M, Eggo R, Babin S, Stajner I, Rogers E, Ensor KB, Raun L, Levy JI, Painter I, Phipatanakul W, Yip F, Nath A, Streichert LC, Tong C, Burkom H.
PMID: 28210420
Online J Public Health Inform. 2016 Dec 28;8(3):e199. doi: 10.5210/ojphi.v8i3.6902. eCollection 2016.

This paper continues an initiative conducted by the International Society for Disease Surveillance with funding from the Defense Threat Reduction Agency to connect near-term analytical needs of public health practice with technical expertise from the global research community. The...

Cite
Reid M, Gunn J, Shah S, et al. Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston. Online J Public Health Inform. 2016;8(3):e199doi: 10.5210/ojphi.v8i3.6902.
Reid, M., Gunn, J., Shah, S., Donovan, M., Eggo, R., Babin, S., Stajner, I., Rogers, E., Ensor, K. B., Raun, L., Levy, J. I., Painter, I., Phipatanakul, W., Yip, F., Nath, A., Streichert, L. C., Tong, C., & Burkom, H. (2016). Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston. Online journal of public health informatics, 8(3), e199. https://doi.org/10.5210/ojphi.v8i3.6902
Reid, Margaret, et al. "Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston." Online journal of public health informatics vol. 8,3 (2016): e199. doi: https://doi.org/10.5210/ojphi.v8i3.6902
Reid M, Gunn J, Shah S, Donovan M, Eggo R, Babin S, Stajner I, Rogers E, Ensor KB, Raun L, Levy JI, Painter I, Phipatanakul W, Yip F, Nath A, Streichert LC, Tong C, Burkom H. Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston. Online J Public Health Inform. 2016 Dec 28;8(3):e199. doi: 10.5210/ojphi.v8i3.6902. eCollection 2016. PMID: 28210420; PMCID: PMC5302473.
Copy Download .nbib Format: NLM
Erratum to: MSRE-HTPrimer: a high-throughput and genome-wide primer design pipeline optimized for epigenetic research.

Clinical epigenetics

Pandey RV, Pulverer W, Kallmeyer R, Beikircher G, Pabinger S, Kriegner A, Weinhäusel A.
PMID: 27493700
Clin Epigenetics. 2016 Aug 04;8:84. doi: 10.1186/s13148-016-0250-1. eCollection 2016.

[This corrects the article DOI: 10.1186/s13148-016-0190-9.].

Cite
Pandey RV, Pulverer W, Kallmeyer R, et al. Erratum to: MSRE-HTPrimer: a high-throughput and genome-wide primer design pipeline optimized for epigenetic research. Clin Epigenetics. 2016;8:84doi: 10.1186/s13148-016-0250-1.
Pandey, R. V., Pulverer, W., Kallmeyer, R., Beikircher, G., Pabinger, S., Kriegner, A., & Weinhäusel, A. (2016). Erratum to: MSRE-HTPrimer: a high-throughput and genome-wide primer design pipeline optimized for epigenetic research. Clinical epigenetics, 884. https://doi.org/10.1186/s13148-016-0250-1
Pandey, Ram Vinay, et al. "Erratum to: MSRE-HTPrimer: a high-throughput and genome-wide primer design pipeline optimized for epigenetic research." Clinical epigenetics vol. 8 (2016): 84. doi: https://doi.org/10.1186/s13148-016-0250-1
Pandey RV, Pulverer W, Kallmeyer R, Beikircher G, Pabinger S, Kriegner A, Weinhäusel A. Erratum to: MSRE-HTPrimer: a high-throughput and genome-wide primer design pipeline optimized for epigenetic research. Clin Epigenetics. 2016 Aug 04;8:84. doi: 10.1186/s13148-016-0250-1. eCollection 2016. PMID: 27493700; PMCID: PMC4973548.
Copy Download .nbib Format: NLM
Impact of new technologies on stress, attrition and well-being in emergency call centers: the NextGeneration 9-1-1 study protocol.

BMC public health

Baseman J, Revere D, Painter I, Stangenes S, Lilly M, Beaton R, Calhoun R, Meischke H.
PMID: 29728094
BMC Public Health. 2018 May 04;18(1):597. doi: 10.1186/s12889-018-5510-x.

BACKGROUND: Our public health emergency response system relies on the "first of the first responders"-the emergency call center workforce that handles the emergency needs of a public in distress. Call centers across the United States have been preparing for...

Cite
Baseman J, Revere D, Painter I, et al. Impact of new technologies on stress, attrition and well-being in emergency call centers: the NextGeneration 9-1-1 study protocol. BMC Public Health. 2018;18(1):597doi: 10.1186/s12889-018-5510-x.
Baseman, J., Revere, D., Painter, I., Stangenes, S., Lilly, M., Beaton, R., Calhoun, R., & Meischke, H. (2018). Impact of new technologies on stress, attrition and well-being in emergency call centers: the NextGeneration 9-1-1 study protocol. BMC public health, 18(1), 597. https://doi.org/10.1186/s12889-018-5510-x
Baseman, Janet, et al. "Impact of new technologies on stress, attrition and well-being in emergency call centers: the NextGeneration 9-1-1 study protocol." BMC public health vol. 18,1 (2018): 597. doi: https://doi.org/10.1186/s12889-018-5510-x
Baseman J, Revere D, Painter I, Stangenes S, Lilly M, Beaton R, Calhoun R, Meischke H. Impact of new technologies on stress, attrition and well-being in emergency call centers: the NextGeneration 9-1-1 study protocol. BMC Public Health. 2018 May 04;18(1):597. doi: 10.1186/s12889-018-5510-x. PMID: 29728094; PMCID: PMC5936032.
Copy Download .nbib Format: NLM
Differential regulation of .

Epigenetics

Wisnieski F, Geraldis JC, Santos LC, Leal MF, Calcagno DQ, Gigek CO, Chen ES, Anauate AC, Artigiani R, Demachki S, Assumpção PP, Lourenço LG, Arasaki CH, Krainer J, Pabinger S, Burbano RR, Smith MAC.
PMID: 33491552
Epigenetics. 2021 Feb 08;1-7. doi: 10.1080/15592294.2021.1878724. Epub 2021 Feb 08.

Gastric cancer (GC) is one of the leading types of fatal cancer worldwide. Epigenetic manipulation of cancer cells is a useful tool to better understand gene expression regulatory mechanisms and contributes to the discovery of novel biomarkers. Our research...

Cite
Wisnieski F, Geraldis JC, Santos LC, et al. Differential regulation of . Epigenetics. 2021;1-7doi: 10.1080/15592294.2021.1878724.
Wisnieski, F., Geraldis, J. C., Santos, L. C., Leal, M. F., Calcagno, D. Q., Gigek, C. O., Chen, E. S., Anauate, A. C., Artigiani, R., Demachki, S., Assumpção, P. P., Lourenço, L. G., Arasaki, C. H., Krainer, J., Pabinger, S., Burbano, R. R., & Smith, M. A. C. (2021). Differential regulation of . Epigenetics, 1-7. https://doi.org/10.1080/15592294.2021.1878724
Wisnieski, Fernanda, et al. "Differential regulation of ." Epigenetics vol. (2021): 1-7. doi: https://doi.org/10.1080/15592294.2021.1878724
Wisnieski F, Geraldis JC, Santos LC, Leal MF, Calcagno DQ, Gigek CO, Chen ES, Anauate AC, Artigiani R, Demachki S, Assumpção PP, Lourenço LG, Arasaki CH, Krainer J, Pabinger S, Burbano RR, Smith MAC. Differential regulation of . Epigenetics. 2021 Feb 08;1-7. doi: 10.1080/15592294.2021.1878724. Epub 2021 Feb 08. PMID: 33491552.
Copy Download .nbib Format: NLM
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study.

Cardiovascular research

Pereyra D, Heber S, Schrottmaier WC, Santol J, Pirabe A, Schmuckenschlager A, Kammerer K, Ammon D, Sorz T, Fritsch F, Hayden H, Pawelka E, Krüger P, Rumpf B, Traugott MT, Glaser P, Firbas C, Schörgenhofer C, Seitz T, Karolyi M, Pabinger I, Brostjan C, Starlinger P, Weiss G, Bellmann-Weiler R, Salzer HJF, Jilma B, Zoufaly A, Assinger A.
PMID: 34609480
Cardiovasc Res. 2021 Dec 17;117(14):2807-2820. doi: 10.1093/cvr/cvab308.

AIMS : Anticoagulation was associated with improved survival of hospitalized coronavirus disease 2019 (COVID-19) patients in large-scale studies. Yet, the development of COVID-19-associated coagulopathy (CAC) and the mechanism responsible for improved survival of anticoagulated patients with COVID-19 remain largely...

Cite
Pereyra D, Heber S, Schrottmaier WC, et al. Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study. Cardiovasc Res. 2021;117(14):2807-2820doi: 10.1093/cvr/cvab308.
Pereyra, D., Heber, S., Schrottmaier, W. C., Santol, J., Pirabe, A., Schmuckenschlager, A., Kammerer, K., Ammon, D., Sorz, T., Fritsch, F., Hayden, H., Pawelka, E., Krüger, P., Rumpf, B., Traugott, M. T., Glaser, P., Firbas, C., Schörgenhofer, C., Seitz, T., Karolyi, M., Pabinger, I., Brostjan, C., Starlinger, P., Weiss, G., Bellmann-Weiler, R., Salzer, H. J. F., Jilma, B., Zoufaly, A., & Assinger, A. (2021). Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study. Cardiovascular research, 117(14), 2807-2820. https://doi.org/10.1093/cvr/cvab308
Pereyra, David, et al. "Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study." Cardiovascular research vol. 117,14 (2021): 2807-2820. doi: https://doi.org/10.1093/cvr/cvab308
Pereyra D, Heber S, Schrottmaier WC, Santol J, Pirabe A, Schmuckenschlager A, Kammerer K, Ammon D, Sorz T, Fritsch F, Hayden H, Pawelka E, Krüger P, Rumpf B, Traugott MT, Glaser P, Firbas C, Schörgenhofer C, Seitz T, Karolyi M, Pabinger I, Brostjan C, Starlinger P, Weiss G, Bellmann-Weiler R, Salzer HJF, Jilma B, Zoufaly A, Assinger A. Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study. Cardiovasc Res. 2021 Dec 17;117(14):2807-2820. doi: 10.1093/cvr/cvab308. PMID: 34609480; PMCID: PMC8500043.
Copy Download .nbib Format: NLM
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report.

HemaSphere

Rodeghiero F, Pabinger I, Ragni M, Abdul-Kadir R, Berntorp E, Blanchette V, Bodó I, Casini A, Gresele P, Lassila R, Leebeek F, Lillicrap D, Mezzano D, Noris P, Srivastava A, Tosetto A, Windyga J, Zieger B, Makris M, Key N.
PMID: 31942541
Hemasphere. 2019 Sep 17;3(4):e286. doi: 10.1097/HS9.0000000000000286. eCollection 2019 Oct.

Healthy subjects frequently report minor bleedings that are frequently 'background noise' of normality rather than a true disorder. Nevertheless, unexpected or unusual bleeding may be alarming. Thus, the distinction between normal and pathologic bleeding is critical. Understanding the underlying...

Cite
Rodeghiero F, Pabinger I, Ragni M, et al. Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report. Hemasphere. 2019;3(4):e286doi: 10.1097/HS9.0000000000000286.
Rodeghiero, F., Pabinger, I., Ragni, M., Abdul-Kadir, R., Berntorp, E., Blanchette, V., Bodó, I., Casini, A., Gresele, P., Lassila, R., Leebeek, F., Lillicrap, D., Mezzano, D., Noris, P., Srivastava, A., Tosetto, A., Windyga, J., Zieger, B., Makris, M., & Key, N. (2019). Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report. HemaSphere, 3(4), e286. https://doi.org/10.1097/HS9.0000000000000286
Rodeghiero, Francesco, et al. "Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report." HemaSphere vol. 3,4 (2019): e286. doi: https://doi.org/10.1097/HS9.0000000000000286
Rodeghiero F, Pabinger I, Ragni M, Abdul-Kadir R, Berntorp E, Blanchette V, Bodó I, Casini A, Gresele P, Lassila R, Leebeek F, Lillicrap D, Mezzano D, Noris P, Srivastava A, Tosetto A, Windyga J, Zieger B, Makris M, Key N. Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report. Hemasphere. 2019 Sep 17;3(4):e286. doi: 10.1097/HS9.0000000000000286. eCollection 2019 Oct. PMID: 31942541; PMCID: PMC6919472.
Copy Download .nbib Format: NLM
Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer.

Cancers

Moik F, Zöchbauer-Müller S, Posch F, Pabinger I, Ay C.
PMID: 32570944
Cancers (Basel). 2020 Jun 18;12(6). doi: 10.3390/cancers12061619.

Systemic inflammation and activation of haemostasis are common in patients with lung cancer. Both conditions support tumour growth and metastasis. Therefore, inflammatory and haemostatic biomarkers might be useful for prediction of survival and therapy response. Patients with unresectable/metastatic lung...

Cite
Moik F, Zöchbauer-Müller S, Posch F, et al. Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer. Cancers (Basel). 2020;12(6)doi: 10.3390/cancers12061619.
Moik, F., Zöchbauer-Müller, S., Posch, F., Pabinger, I., & Ay, C. (2020). Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer. Cancers, 12(6), . https://doi.org/10.3390/cancers12061619
Moik, Florian, et al. "Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer." Cancers vol. 12,6 (2020). doi: https://doi.org/10.3390/cancers12061619
Moik F, Zöchbauer-Müller S, Posch F, Pabinger I, Ay C. Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer. Cancers (Basel). 2020 Jun 18;12(6). doi: 10.3390/cancers12061619. PMID: 32570944; PMCID: PMC7352812.
Copy Download .nbib Format: NLM
Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia.

Thrombosis research

Thaler J, Jilma P, Samadi N, Roitner F, Mikušková E, Kudrnovsky-Moser S, Rettl J, Preiss R, Quehenberger P, Pabinger I, Knoebl P, Ay C.
PMID: 34624672
Thromb Res. 2021 Oct 04;207:126-130. doi: 10.1016/j.thromres.2021.09.017. Epub 2021 Oct 04.

BACKGROUND: Cases of ChAdOx1 nCoV-19 (AstraZeneca) vaccinated patients with thrombocytopenia, elevated D-dimer, and elevated platelet factor 4 (PF4) antibody levels with- and without thrombosis have been reported. No recommendations regarding the duration of anticoagulation have been made, because data...

Cite
Thaler J, Jilma P, Samadi N, et al. Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thromb Res. 2021;207:126-130doi: 10.1016/j.thromres.2021.09.017.
Thaler, J., Jilma, P., Samadi, N., Roitner, F., Mikušková, E., Kudrnovsky-Moser, S., Rettl, J., Preiss, R., Quehenberger, P., Pabinger, I., Knoebl, P., & Ay, C. (2021). Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thrombosis research, 207126-130. https://doi.org/10.1016/j.thromres.2021.09.017
Thaler, Johannes, et al. "Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia." Thrombosis research vol. 207 (2021): 126-130. doi: https://doi.org/10.1016/j.thromres.2021.09.017
Thaler J, Jilma P, Samadi N, Roitner F, Mikušková E, Kudrnovsky-Moser S, Rettl J, Preiss R, Quehenberger P, Pabinger I, Knoebl P, Ay C. Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thromb Res. 2021 Oct 04;207:126-130. doi: 10.1016/j.thromres.2021.09.017. Epub 2021 Oct 04. PMID: 34624672.
Copy Download .nbib Format: NLM
Implementing thrombosis guidelines in cancer patients: a review.

Rambam Maimonides medical journal

Farge-Bancel D, Bounameaux H, Brenner B, Büller HR, Kakkar A, Pabinger I, Streiff M, Debourdeau P.
PMID: 25386357
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0041. doi: 10.5041/RMMJ.10175. eCollection 2014 Oct.

Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as...

Cite
Farge-Bancel D, Bounameaux H, Brenner B, et al. Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J. 2014;5(4):e0041doi: 10.5041/RMMJ.10175.
Farge-Bancel, D., Bounameaux, H., Brenner, B., Büller, H. R., Kakkar, A., Pabinger, I., Streiff, M., & Debourdeau, P. (2014). Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides medical journal, 5(4), e0041. https://doi.org/10.5041/RMMJ.10175
Farge-Bancel, Dominique, et al. "Implementing thrombosis guidelines in cancer patients: a review." Rambam Maimonides medical journal vol. 5,4 (2014): e0041. doi: https://doi.org/10.5041/RMMJ.10175
Farge-Bancel D, Bounameaux H, Brenner B, Büller HR, Kakkar A, Pabinger I, Streiff M, Debourdeau P. Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J. 2014 Oct 29;5(4):e0041. doi: 10.5041/RMMJ.10175. eCollection 2014 Oct. PMID: 25386357; PMCID: PMC4222430.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries